Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth R Gerstner

Showing results (111-120 of 133) with videos related to

Pageof 14
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|November 6, 2013
Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiationTracy T Batchelor, Elizabeth R Gerstner, Kyrre E Emblem, et al.
Nature Cancer|February 5, 2022
Palbociclib demonstrates intracranial activity in progressive brain metastases harboring cyclin-dependent kinase pathway alterationsPriscilla K Brastianos, Albert E Kim, Nancy Wang, et al.
Neuro-Oncology|June 10, 2020
Consensus recommendations for a dynamic susceptibility contrast MRI protocol for use in high-grade gliomasJerrold L Boxerman, Chad C Quarles, Leland S Hu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 24, 2017
Residual Convolutional Neural Network for the Determination of <i>IDH</i> Status in Low- and High-Grade Gliomas from MR ImagingKen Chang, Harrison X Bai, Hao Zhou, et al.
Neuro-Oncology|December 15, 2025
Prognostic Significance of MGMT Promoter Methylation Status in IDH-mutant GliomaGilbert Youssef, Elisa Aquilanti, Julie J Miller, et al.
The New England Journal of Medicine|July 12, 2023
BRAF-MEK Inhibition in Newly Diagnosed Papillary CraniopharyngiomasPriscilla K Brastianos, Erin Twohy, Susan Geyer, et al.
Nature Communications|March 15, 2022
Phase 2 study of pembrolizumab in patients with recurrent and residual high-grade meningiomasPriscilla K Brastianos, Albert E Kim, Anita Giobbie-Hurder, et al.
Neuro-Oncology|June 14, 2019
Automatic assessment of glioma burden: a deep learning algorithm for fully automated volumetric and bidimensional measurementKen Chang, Andrew L Beers, Harrison X Bai, et al.
International Journal of Radiation Oncology, Biology, Physics|July 4, 2018
The Use of Quantitative Imaging in Radiation Oncology: A Quantitative Imaging Network (QIN) PerspectiveRobert H Press, Hui-Kuo G Shu, Hyunsuk Shim, et al.
Neuro-Oncology|April 17, 2018
Validation of postoperative residual contrast-enhancing tumor volume as an independent prognostic factor for overall survival in newly diagnosed glioblastomaBenjamin M Ellingson, Lauren E Abrey, Sarah J Nelson, et al.
Pageof 14

Showing results (111-120 of 133) with videos related to

Sort By:
Pageof 14
Proceedings of the National Academy of Sciences of the United States of America|November 6, 2013
Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiationTracy T Batchelor, Elizabeth R Gerstner, Kyrre E Emblem, et al.
Nature Cancer|February 5, 2022
Palbociclib demonstrates intracranial activity in progressive brain metastases harboring cyclin-dependent kinase pathway alterationsPriscilla K Brastianos, Albert E Kim, Nancy Wang, et al.
Neuro-Oncology|June 10, 2020
Consensus recommendations for a dynamic susceptibility contrast MRI protocol for use in high-grade gliomasJerrold L Boxerman, Chad C Quarles, Leland S Hu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 24, 2017
Residual Convolutional Neural Network for the Determination of <i>IDH</i> Status in Low- and High-Grade Gliomas from MR ImagingKen Chang, Harrison X Bai, Hao Zhou, et al.
Neuro-Oncology|December 15, 2025
Prognostic Significance of MGMT Promoter Methylation Status in IDH-mutant GliomaGilbert Youssef, Elisa Aquilanti, Julie J Miller, et al.
The New England Journal of Medicine|July 12, 2023
BRAF-MEK Inhibition in Newly Diagnosed Papillary CraniopharyngiomasPriscilla K Brastianos, Erin Twohy, Susan Geyer, et al.
Nature Communications|March 15, 2022
Phase 2 study of pembrolizumab in patients with recurrent and residual high-grade meningiomasPriscilla K Brastianos, Albert E Kim, Anita Giobbie-Hurder, et al.
Neuro-Oncology|June 14, 2019
Automatic assessment of glioma burden: a deep learning algorithm for fully automated volumetric and bidimensional measurementKen Chang, Andrew L Beers, Harrison X Bai, et al.
International Journal of Radiation Oncology, Biology, Physics|July 4, 2018
The Use of Quantitative Imaging in Radiation Oncology: A Quantitative Imaging Network (QIN) PerspectiveRobert H Press, Hui-Kuo G Shu, Hyunsuk Shim, et al.
Neuro-Oncology|April 17, 2018
Validation of postoperative residual contrast-enhancing tumor volume as an independent prognostic factor for overall survival in newly diagnosed glioblastomaBenjamin M Ellingson, Lauren E Abrey, Sarah J Nelson, et al.
Pageof 14